Today: 29 January 2026
Subscribe
Browse Category

NASDAQ:SBRA News 4 January 2026 - 6 January 2026

Sabra Health Care REIT (SBRA) stock slips in premarket after naming new chief investment officer

Sabra Health Care REIT (SBRA) stock slips in premarket after naming new chief investment officer

New York, Jan 6, 2026, 08:00 EST — Premarket Shares of Sabra Health Care REIT, Inc. fell 0.4% to $19.08 in premarket trading on Tuesday after the healthcare landlord disclosed a chief investment officer transition. A regulatory filing showed Darrin Smith will also serve as secretary and executive vice president, while Chief Financial Officer Michael Costa takes on the treasurer…
6 January 2026
···
MPW stock ends higher to start 2026 as investors watch rates and Medical Properties Trust’s dividend

MPW stock ends higher to start 2026 as investors watch rates and Medical Properties Trust’s dividend

NEW YORK, January 3, 2026, 17:44 ET — Market closed Medical Properties Trust, Inc. (NYSE: MPW) shares climbed 1.6% on Friday to close at $5.08. U.S. markets are closed on Saturday. Nasdaq The move matters because MPW is a high-yield real estate investment trust, or REIT — a structure that typically returns a large share of taxable income to investors…
4 January 2026
·········

Stock Market Today

  • CBRE Group Valuation Update: Shares Show Steady Gains but Face High P/E Concerns
    January 29, 2026, 8:22 AM EST. CBRE Group's (NYSE: CBRE) shares have gained 10.9% over the past 90 days and delivered a 19.7% total return in one year, indicating steady compounding. The stock trades at $169.50, about 8.3% below a fair value estimate of $184.83, driven by projections of revenue growth and higher profit margins. However, its price-to-earnings (P/E) ratio stands at 40.5, significantly above the peer average of 29.3 and a fair P/E of 25.8, highlighting potential valuation risks. Investors should balance the appeal of steady growth against risks like interest rate volatility and slowing real estate transactions that may weigh on revenue. The onus is on individual analysis to interpret these mixed signals for CBRE's near-term prospects.
Go toTop